title: Characterization of methylene diphenyl diisocyanate-haptenated human serum albumin and hemoglobin.
abstract: Protein haptenation by polyurethane industrial intermediate 4,4'-methylene diphenyl diisocyanate (MDI) is thought to be an important step in the development of diisocyanate (dNCO)-specific allergic sensitization; however, MDI-haptenated albumins used to screen specific antibody are often poorly characterized. Recently, the need to develop standardized immunoassays using a consistent, well-characterized dNCO-haptenated protein to screen for the presence of MDI-specific IgE and IgG from workers' sera has been emphasized and recognized. This has been challenging to achieve due to the bivalent electrophilic nature of dNCOs, leading to the capability to produce multiple cross-linked protein species and polymeric additions to proteins. In the current study, MDI was reacted with human serum albumin (HSA) and hemoglobin (Hb) at molar ratios ranging from 1:1 to 40:1 MDI/protein. Adducts were characterized by (i) loss of available 2,4,6-trinitrobenzene sulfonic acid (TNBS) binding to primary amines, (ii) electrophoretic migration in polyacrylamide gels, (iii) quantification of methylene diphenyl diamine following acid hydrolysis, and (iv) immunoassay. Concentration-dependent changes in all of the above noted parameters were observed, demonstrating increases in both number and complexity of conjugates formed with increasing MDI concentrations. In conclusion, a series of bioanalytical assays should be performed to standardize MDI-antigen preparations across lots and laboratories for measurement of specific antibody in exposed workers that in total indicate degree of intra- and intermolecular cross-linking, number of dNCOs bound, number of different specific binding sites on the protein, and degree of immunoreactivity.
authors.affiliation: Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, USA.
authors.forename: Morgen
authors.initials: M
authors.lastname: Mhike
authors.forename: Itai
authors.initials: I
authors.lastname: Chipinda
authors.forename: Justin M
authors.initials: JM
authors.lastname: Hettick
authors.forename: Reuben H
authors.initials: RH
authors.lastname: Simoyi
authors.forename: Angela
authors.initials: A
authors.lastname: Lemons
authors.forename: Brett J
authors.initials: BJ
authors.lastname: Green
authors.forename: Paul D
authors.initials: PD
authors.lastname: Siegel
mesh_terms: D001665:Binding Sites; D004797:Enzyme-Linked Immunosorbent Assay; D006241:Haptens / Q000378:metabolism*; D006454:Hemoglobins / Q000378:metabolism*; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology / Q000378:metabolism*; D007074:Immunoglobulin G / Q000276:immunology; D017953:Isocyanates / Q000378:metabolism*; D012709:Serum Albumin / Q000276:immunology / Q000378:metabolism*; D001559:Benzhydryl Compounds
chemical_list: D006241:Haptens; D006454:Hemoglobins; D007073:Immunoglobulin E; D007074:Immunoglobulin G; D017953:Isocyanates; D012709:Serum Albumin; C005969:4,4'-diphenylmethane diisocyanate; D001559:Benzhydryl Compounds
keywords: Hemoglobin; Human serum albumin; Immunoassay standardization; Methylene diphenyl diisocyanate; Occupational asthma